Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events-Reference-Cited by-同舟云学术

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events

Published:2020-01-21 Issue:1 Volume:10 Page:221-229
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Kim Yoo Jung,Cohen Philip R.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

http://link.springer.com/content/pdf/10.1007/s13555-020-00353-3.pdf

Reference20 articles.

1. Jameera Begam A, Jubie S, Nanjan MJ. Estrogen receptor agonists/antagonists in breast cancer therapy: a critical review. Bioorg Chem. 2017;71:257–74.

2. Robert NJ, Denduluri N. Patient case lessons: endocrine management of advanced breast cancer. Clin Breast Cancer. 2018;18:192–204.

3. Jhaveri K, Halperin P, Shin SJ, Vahdat L. Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature. Breast Cancer Res Treat. 2007;106:315–8.

4. Wong M, Grossman J, Hahn BH, La Cava A. Cutaneous vasculitis in breast cancer treated with chemotherapy. Clin Immunol. 2008;129:3–9.

5. Digklia A, Tzika E, Voutsadakis IA. Cutaneous leukocytoclastic vasculitis associated with letrozole. J Oncol Pharm Pract. 2014;20:146–8.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palbociclib-induced subacute cutaneous lupus erythematosus;Annales de Dermatologie et de Vénéréologie;2024-06

2. Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience;Supportive Care in Cancer;2024-02-29

3. The impact of hormones in autoimmune cutaneous diseases;Journal of Dermatological Treatment;2024-02-05

4. Development of Erythema Nodosum After Olaparib Treatment in a Patient With Recurrent Breast Cancer and BRCA2 Mutation: A Case Report;Cureus;2023-09-07

5. Anastrozole‐related dermatitis with mainly unilateral distribution;Australasian Journal of Dermatology;2022-02-23